Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.95 USD | -0.02% | -0.26% | +15.41% |
May. 30 | Barrington Research Downgrades SurModics to Market Perform From Outperform | MT |
May. 29 | Needham Downgrades SurModics to Hold From Buy | MT |
Chart calendar Surmodics, Inc.
Upcoming events on Surmodics, Inc.
Past events on Surmodics, Inc.
2024-05-01 08:00 am | Q2 2024 Earnings Call |
2024-05-01 07:00 am | Q2 2024 Earnings Release |
2024-04-09 03:00 pm | Needham Healthcare Conference |
2024-03-13 02:00 pm | Oppenheimer Healthcare MedTech & Services Conference |
2024-02-08 05:00 pm | Annual General Meeting |
2024-02-01 08:00 am | Q1 2024 Earnings Call |
2024-02-01 07:00 am | Q1 2024 Earnings Release |
2023-11-28 08:30 am | Piper Sandler Healthcare Conference |
2023-11-15 09:18 am | VEITH Symposium |
2023-11-08 08:00 am | Q4 2023 Earnings Call |
2023-11-08 07:30 am | Q4 2023 Earnings Release |
2023-08-16 10:45 am | Sidoti Micro Cap Conference |
2023-08-13 | Needham Virtual MedTech & Diagnostics Conference |
2023-08-02 08:00 am | Q3 2023 Earnings Call |
2023-08-02 07:31 am | Q3 2023 Earnings Release |
2023-06-08 01:30 pm | Jefferies Global Healthcare Conference |
2023-04-26 08:00 am | Q2 2023 Earnings Call |
2023-04-26 07:00 am | Q2 2023 Earnings Release |
2023-04-20 10:15 am | Needham Virtual Healthcare Conference |
2023-03-21 | Sidoti Spring Small-Cap Conference |
Annual results
Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 100 97,6 2.53% | 94,9 93,1 1.92% | 105 104 0.95% | 100,0 98,0 1.94% | 133 131 1.3% | 123 |
EBITDA Million USD | Released Forecast Spread | 14,1 13,1 7.84% | 5,77 5,75 0.26% | 12,0 10,9 10.8% | -12,9 -14,9 13.45% | 13,9 9,20 50.8% | 9,24 |
EBIT Million USD | Released Forecast Spread | 6,47 5,75 12.58% | -1,25 -1,57 20.53% | 6,70 2,90 131.48% | -22,1 -24,5 9.67% | 5,60 1,59 251.84% | -7,56 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 7,56 6,70 12.88% | -1,45 -1,73 15.93% | 6,35 2,60 143.84% | -22,5 -24,7 8.84% | 2,49 -1,61 254.26% | -10,7 |
Net income Million USD | Released Forecast Spread | 7,59 7,50 1.24% | 1,12 1,93 -41.93% | 4,24 0,46 820.09% | -27,3 -19,9 -36.91% | -1,54 -6,37 75.87% | -11,0 |
EPS USD | Released Forecast Spread | 0,55 0,55 0.92% | 0,08 0,14 -42.86% | 0,30 0,04 757.14% | -1,96 -1,44 -36.59% | -0,11 -0,45 75.56% | -0,78 |
Announcement Date | 31/10/19 | 04/11/20 | 10/11/21 | 09/11/22 | 08/11/23 | - |
Quarterly results
Fiscal Period | September | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 26,1 24,0 8.89% | 24,9 25,2 -1.35% | 26,0 24,1 7.87% | 24,9 24,0 4.03% | 27,2 25,9 5.18% | 52,5 38,1 37.88% | 28,0 26,3 6.46% | 30,6 29,6 3.06% | 32,0 28,8 10.8% | 30,0 | 30,5 | 33,2 | 35,0 | 35,1 |
EBITDA Million USD | Released Forecast Spread | -2,58 -4,15 37.88% | -4,85 -4,60 -5.48% | -4,39 -6,40 31.41% | -5,23 -6,90 24.17% | -3,28 -4,45 26.2% | 23,5 18,2 29.13% | -0,28 -4,50 93.71% | 1,97 0,45 337.21% | 4,81 0,03 15755.59% | 0,64 | 0,50 | 3,09 | 3,89 | 5,11 |
EBIT Million USD | Released Forecast Spread | -4,90 -6,92 29.15% | -7,14 -7,52 4.99% | -6,61 -8,97 26.29% | -7,23 -9,28 22.06% | -5,30 -7,82 32.2% | 21,4 1,38 1453.47% | -2,45 -6,01 59.22% | -0,32 -3,79 91.51% | 0,66 -4,36 115.11% | -4,08 | -3,80 | -0,47 | 0,22 | 1,22 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,00 -6,94 27.94% | -7,18 -7,54 4.82% | -6,79 -8,97 24.3% | -8,01 -10,1 20.56% | -7,37 -8,64 14.72% | 20,6 0,52 3870.96% | -2,79 -6,88 59.43% | -0,72 -4,49 83.89% | 0,17 -5,26 103.15% | -5,16 | -4,91 | -0,91 | -0,20 | 0,83 |
Net income Million USD | Released Forecast Spread | -4,08 -5,85 30.24% | -5,65 -6,33 10.67% | -14,7 -7,37 -99.74% | -7,84 -10,0 21.8% | -7,73 -8,52 9.25% | 7,35 0,15 4690.97% | 6,69 1,88 257.01% | -0,79 -5,13 84.69% | 0,25 -5,71 104.32% | -5,43 | -5,09 | -1,07 | -0,39 | 0,60 |
EPS USD | Released Forecast Spread | -0,29 -0,43 31.76% | -0,41 -0,46 10.38% | -1,06 -0,53 -99.06% | -0,56 -0,72 21.68% | -0,55 -0,61 9.47% | 0,52 -0,50 204% | 0,47 0,13 254.72% | -0,06 -0,36 83.45% | 0,02 -0,40 105.06% | -0,38 | -0,36 | -0,07 | -0,02 | 0,05 |
Announcement Date | 27/04/22 | 27/07/22 | 09/11/22 | 06/02/23 | 26/04/23 | 02/08/23 | 08/11/23 | 01/02/24 | 01/05/24 | - | - | - | - | - |
2024-06-18 | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release (Projected) |
2024-06-26 | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
2024-07-04 | MANI, INC.: Q3 2024 Earnings Release |
2024-07-11 01:00 am | GERRESHEIMER AG: Q2 2024 Earnings Release |
2024-07-11 | ARJO AB: Q2 2024 Earnings Release |
2024-07-12 01:30 am | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
2024-07-17 | ABBOTT LABORATORIES: Q2 2024 Earnings Release (Projected) |
2024-07-17 | MEDMIX AG: Q2 2024 Earnings Release |
2024-07-19 01:00 am | SARTORIUS STEDIM BIOTECH: Q2 2024 Earnings Release |
2024-07-22 | NEOGEN CORPORATION: Q4 2024 Earnings Release (Projected) |
Past sector events for Surmodics, Inc.
2024-06-05 06:00 am | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
2024-05-27 04:30 pm | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
2024-05-23 06:45 am | MEDTRONIC PLC: Q4 2024 Earnings Release |
2024-05-22 01:00 am | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
2024-05-17 04:19 am | POLY MEDICURE LIMITED: Q4 2024 Earnings Release |
2024-05-16 02:00 am | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
2024-05-14 10:00 pm | HOYA CORPORATION: Q4 2023 Earnings Release |
2024-05-14 01:00 am | AMBU A/S: Q2 2024 Earnings Release |
2024-05-13 | HLB CO., LTD.: Q1 2024 Earnings Release |
2024-05-13 | TERUMO CORPORATION: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SRDX Stock
- Calendar Surmodics, Inc.